|
2019
|
Invention
|
Alphavirus replicon particles expressing trp2.
The immune response to melanoma cells and tumors ... |
|
2016
|
Invention
|
Tc-83-derived alphavirus vectors, particles and methods. The present disclosure provides TC-83 VE... |
|
|
Invention
|
Alphavirus replicon particles matched to protein antigens as immunological adjuvants. The immune ... |
|
2014
|
Invention
|
Use of micrornas to control virus helper nucleic acids. Provided herein are helper nucleic acids ... |
|
2011
|
Invention
|
Alphavirus and alphavirus replicon particle formulations and methods. Disclosed are methods for p... |
|
2010
|
Invention
|
Alphavirus replicon particles expressing trp2. The immune response to melanoma cells and tumors c... |
|
2009
|
Invention
|
Nucleic acids encoding modified south african hiv-1 subtype c gag proteins. Embodiments of the in... |
|
2008
|
Invention
|
Promoterless cassettes for expression of alpha virus structural proteins. The present invention p... |
|
|
Invention
|
Promoterless cassettes for expression of alphavirus structural proteins. The present invention pr... |
|
|
Invention
|
Multi-antigenic alphavirus replicon particles and methods. Viral replicon selected nucleic acid e... |
|
2007
|
Invention
|
Alphavirus and alphavirus replicon particle formulations and methods.
Disclosed are methods for ... |
|
|
Invention
|
Alphavirus replicon particles as immunological adjuvants. The immune response to an antigen of in... |
|
|
Invention
|
Alphavirus replicon particles encoding il- 12 as immunological adjuvants. The immune response to ... |
|
|
Invention
|
Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their gen... |
|
2006
|
Invention
|
Alphavirus replicon vector systems. The present invention provides compositions useful in and met... |
|
2005
|
Invention
|
Tc-83-derived alphavirus vectors, particles and methods.
The present disclosure provides TC-83 V... |
|
|
Invention
|
Tc-83-derived alphavirus vectors, particles and methods.
The present disclosure provid... |
|
2004
|
Invention
|
Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alph... |
|
|
Invention
|
Alpha virus-based cytomegalovirus vaccines. The present invention provides methods and compositio... |
|
|
Invention
|
Alphavirus-based cytomegalovirus vaccines. The present invention provides methods and composition... |
|
|
Invention
|
Alphavirus replicons and helper constructs. The present invention provides a recombinant nucleic ... |
|
|
Invention
|
Improved alphavirus replicons and helper constructs. The present invention provides a recombinant... |
|
|
Invention
|
Improved alphavirus replicons and helper constructs.
The present invention provides a ... |
|
2003
|
Invention
|
Alphavirus particles and methods for preparation. Provided herein are methods for producing alpha... |
|
|
Invention
|
Multi-antigenic alphavirus replicon particles and methods.
Viral replicon selected nuc... |
|
|
Invention
|
Alphavirus particles and methods for preparation.
Provided herein are methods for prod... |
|
|
Invention
|
Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype c isolates, their g... |
|
|
Invention
|
Alphavirus vectors having attentuated virion structural proteins.
The present invention provides... |
|
|
Invention
|
Improved alphavirus vectors having attenuated virion structural proteins. The present invention p... |
|
2002
|
Invention
|
Alphavirus replicon vector systems.
The present invention provides compositions useful... |
|
2001
|
Invention
|
Alphavirus vectors and virosomes with modified hiv genes for use in vaccines. The present inventi... |
|
|
Invention
|
Alphavirus vectors and virosomes with modified hiv genes for use as vaccines. The present inventi... |
|
1998
|
P/S
|
Research and Development in the fields of preventative and therapeutic vaccine and gene therapy f... |
